Fact CheckerSign in

NCT05542355CompletedPhase 1

A Phase 1 Study to Evaluate the Safety and Target Engagement of EXL01 in the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Mild to Moderate Crohn's Disease

Source: EU CTIS (euclinicaltrials.eu) · Last updated 24 Nov 2023

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
50 (actual)
First submitted
15 Jun 2023
Start date
20 Mar 2023
Lead sponsor
Exeliom Biosciences
NCT number
NCT05542355
EU CT number
2022-502241-99-00
EudraCT number
2021-003432-81

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 50
  • 10 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Sites (10)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Imelda
Coordinator of this site? Confirm its status
BonheidenBelgiumCompleted
CHU de Liège
Coordinator of this site? Confirm its status
LiègeBelgiumCompleted
Oddział Gastroenterologiczny SPZOZ w Łęczne
Coordinator of this site? Confirm its status
LccznaPolandCompleted
Medrise Sp. z o.o.
Coordinator of this site? Confirm its status
LublinPolandCompleted
Centrum Medyczne "Medyk" Sp. zo.o. Sp.K
Coordinator of this site? Confirm its status
RzeszowPolandCompleted
Endoskopia Sp z o.o.
Coordinator of this site? Confirm its status
SopotPolandCompleted
WIP Warsaw IBD Point Profesor Kierkuś
Coordinator of this site? Confirm its status
WarszawaPolandCompleted
Niepubliczny Zakład Opieki Zdrowotnej - Vivamed
Coordinator of this site? Confirm its status
WarszawaPolandCompleted
Centrum Zdrowia MDM
Coordinator of this site? Confirm its status
WarszawaPolandCompleted
PlanetMed Sp. z o.o.
Coordinator of this site? Confirm its status
WroclawPolandCompleted

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.